Skip to main content
medichelpline
Back to Drug Index
General MedicationsORALStandard

MERCAPTOPURINE

MERCAPTOPURINE

Standard Dose
20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview MERCAPTOPURINE is listed in Drugs@FDA under application 216418 (ANDA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient MERCAPTOPURINE Form and strength SUSPENSION;ORAL - 20MG/ML Sponsor HIKMA Submission history Latest submission status date: 2025-02-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview MERCAPTOPURINE is listed in Drugs@FDA under application 216418 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MERCAPTOPURINE Form and strength SUSPENSION;ORAL - 20MG/ML Sponsor HIKMA Submission history Latest submission status date: 2025-02-26 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.